Amgen (AMGN) Other financing activities (2009 - 2026)

Amgen's Other financing activities history runs 18 years deep, the most recent figure standing at -$104.0 million for Q1 2026.

• In Q1 2026, Other financing activities fell 285.19% year-over-year to -$104.0 million; the TTM figure through Mar 2026 stood at -$129.0 million (down 111.48% YoY), while the FY2025 annual figure was -$52.0 million, up 58.06% from the prior year.
• Other financing activities was -$104.0 million for Q1 2026 at Amgen, down from $57.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $57.0 million in Q4 2025 to a low of -$104.0 million in Q1 2026.
• Historically, Other financing activities has averaged -$26.8 million across 5 years, with a median of -$26.0 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Other financing activities surged 2950.0% in 2025, then tumbled 285.19% in 2026.
• A 5-year view of Other financing activities shows it stood at $10.0 million in 2022, then tumbled by 150.0% to -$5.0 million in 2023, then jumped by 60.0% to -$2.0 million in 2024, then soared by 2950.0% to $57.0 million in 2025, then plunged by 282.46% to -$104.0 million in 2026.
• The last three Other financing activities figures came in at -$104.0 million (Q1 2026), $57.0 million (Q4 2025), and $10.0 million (Q3 2025), per Business Quant data.